These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 28342891

  • 1. Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study).
    Luciano JV, D'Amico F, Feliu-Soler A, McCracken LM, Aguado J, Peñarrubia-María MT, Knapp M, Serrano-Blanco A, García-Campayo J.
    J Pain; 2017 Jul; 18(7):868-880. PubMed ID: 28342891
    [Abstract] [Full Text] [Related]

  • 2. Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.
    Luciano JV, D'Amico F, Cerdà-Lafont M, Peñarrubia-María MT, Knapp M, Cuesta-Vargas AI, Serrano-Blanco A, García-Campayo J.
    Arthritis Res Ther; 2014 Oct 01; 16(5):451. PubMed ID: 25270426
    [Abstract] [Full Text] [Related]

  • 3. Effectiveness of group acceptance and commitment therapy for fibromyalgia: a 6-month randomized controlled trial (EFFIGACT study).
    Luciano JV, Guallar JA, Aguado J, López-Del-Hoyo Y, Olivan B, Magallón R, Alda M, Serrano-Blanco A, Gili M, Garcia-Campayo J.
    Pain; 2014 Apr 01; 155(4):693-702. PubMed ID: 24378880
    [Abstract] [Full Text] [Related]

  • 4. A systematic review of pharmacoeconomic studies for pregabalin.
    Parker L, Huelin R, Khankhel Z, Wasiak R, Mould J.
    Pain Pract; 2015 Jan 01; 15(1):82-94. PubMed ID: 24815038
    [Abstract] [Full Text] [Related]

  • 5. Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective.
    Choy E, Richards S, Bowrin K, Watson P, Lloyd A, Sadosky A, Zlateva G.
    Curr Med Res Opin; 2010 Apr 01; 26(4):965-75. PubMed ID: 20178405
    [Abstract] [Full Text] [Related]

  • 6. Cost-Effectiveness and Cost-Utility of Internet-Delivered Exposure Therapy for Fibromyalgia: Results From a Randomized, Controlled Trial.
    Hedman-Lagerlöf M, Hedman-Lagerlöf E, Ljótsson B, Wicksell RK, Flink I, Andersson E.
    J Pain; 2019 Jan 01; 20(1):47-59. PubMed ID: 30107241
    [Abstract] [Full Text] [Related]

  • 7. Cost-utility of a psychoeducational intervention in fibromyalgia patients compared with usual care: an economic evaluation alongside a 12-month randomized controlled trial.
    Luciano JV, Sabes-Figuera R, Cardeñosa E, T Peñarrubia-María M, Fernández-Vergel R, García-Campayo J, Knapp M, Serrano-Blanco A.
    Clin J Pain; 2013 Aug 01; 29(8):702-11. PubMed ID: 23328339
    [Abstract] [Full Text] [Related]

  • 8. A guided and unguided internet- and mobile-based intervention for chronic pain: health economic evaluation alongside a randomised controlled trial.
    Paganini S, Lin J, Kählke F, Buntrock C, Leiding D, Ebert DD, Baumeister H.
    BMJ Open; 2019 Apr 09; 9(4):e023390. PubMed ID: 30967405
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness and cost-utility of an Acceptance and Commitment Therapy intervention vs. a Cognitive Behavioral Therapy intervention for older adults with anxiety symptoms: A randomized controlled trial.
    Witlox M, Kraaij V, Garnefski N, Bohlmeijer E, Smit F, Spinhoven P.
    PLoS One; 2022 Apr 09; 17(1):e0262220. PubMed ID: 35081130
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of cognitive behaviour therapy for the treatment of catastrophisation in patients with fibromyalgia: a randomised controlled trial.
    Alda M, Luciano JV, Andrés E, Serrano-Blanco A, Rodero B, del Hoyo YL, Roca M, Moreno S, Magallón R, García-Campayo J.
    Arthritis Res Ther; 2011 Apr 09; 13(5):R173. PubMed ID: 22018333
    [Abstract] [Full Text] [Related]

  • 11. Cost-Utility of Mindfulness-Based Stress Reduction for Fibromyalgia versus a Multicomponent Intervention and Usual Care: A 12-Month Randomized Controlled Trial (EUDAIMON Study).
    Pérez-Aranda A, D'Amico F, Feliu-Soler A, McCracken LM, Peñarrubia-María MT, Andrés-Rodríguez L, Angarita-Osorio N, Knapp M, García-Campayo J, Luciano JV.
    J Clin Med; 2019 Jul 20; 8(7):. PubMed ID: 31330832
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness analysis of pharmacologic treatment of fibromyalgia in Mexico.
    Arreola Ornelas H, Rosado Buzzo A, García L, Dorantes Aguilar J, Contreras Hernández I, Mould Quevedo JF.
    Reumatol Clin; 2012 Jul 20; 8(3):120-7. PubMed ID: 22386298
    [Abstract] [Full Text] [Related]

  • 13. Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine.
    Harnett J, Margolis J, Cao Z, Fowler R, Sanchez RJ, Mardekian J, Silverman SL.
    Pain Pract; 2011 Jul 20; 11(3):217-29. PubMed ID: 21199319
    [Abstract] [Full Text] [Related]

  • 14. Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.
    Burke JP, Sanchez RJ, Joshi AV, Cappelleri JC, Kulakodlu M, Halpern R.
    Pain Pract; 2012 Jan 20; 12(1):14-22. PubMed ID: 21615857
    [Abstract] [Full Text] [Related]

  • 15. Randomized Controlled Trial of Online Acceptance and Commitment Therapy for Fibromyalgia.
    Simister HD, Tkachuk GA, Shay BL, Vincent N, Pear JJ, Skrabek RQ.
    J Pain; 2018 Jul 20; 19(7):741-753. PubMed ID: 29481976
    [Abstract] [Full Text] [Related]

  • 16. Internet-delivered acceptance and values-based exposure treatment for fibromyalgia: a pilot study.
    Ljótsson B, Atterlöf E, Lagerlöf M, Andersson E, Jernelöv S, Hedman E, Kemani M, Wicksell RK.
    Cogn Behav Ther; 2014 Jul 20; 43(2):93-104. PubMed ID: 24215278
    [Abstract] [Full Text] [Related]

  • 17. An economic evaluation of pregabalin versus usual care in the management of community-treated patients with refractory painful diabetic peripheral neuropathy in primary care settings.
    de Salas-Cansado M, Pérez C, Saldaña MT, Navarro A, González-Gómez FJ, Ruiz L, Rejas J.
    Prim Care Diabetes; 2012 Dec 20; 6(4):303-12. PubMed ID: 22595032
    [Abstract] [Full Text] [Related]

  • 18. Cognitive-educational treatment of fibromyalgia: a randomized clinical trial. II. Economic evaluation.
    Goossens ME, Rutten-van Mölken MP, Leidl RM, Bos SG, Vlaeyen JW, Teeken-Gruben NJ.
    J Rheumatol; 1996 Jul 20; 23(7):1246-54. PubMed ID: 8823700
    [Abstract] [Full Text] [Related]

  • 19. The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective.
    Lloyd A, Boomershine CS, Choy EH, Chandran A, Zlateva G.
    J Med Econ; 2012 Jul 20; 15(3):481-92. PubMed ID: 22339078
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of Spa treatment for fibromyalgia: general health improvement is not for free.
    Zijlstra TR, Braakman-Jansen LM, Taal E, Rasker JJ, van de Laar MA.
    Rheumatology (Oxford); 2007 Sep 20; 46(9):1454-9. PubMed ID: 17636181
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.